A36.9
Diphtheria, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Diphtheria is a serious bacterial infection caused by Corynebacterium diphtheriae. It primarily affects the mucous membranes of the throat and nose but can also impact the skin and other parts of the body. Once a common infectious disease, diphtheria has become rare in many parts of the world thanks to widespread vaccination efforts. However, it remains a concern in areas with low immunization coverage. The ICD-10 code A36.9 refers to cases of diphtheria where the specific location or manifestation has not been further specified.
Causes & Symptoms
Clinical Causes: Infection with the bacteria Corynebacterium diphtheriae Person-to-person contact through respiratory droplets from coughs or sneezes touching contaminated objects or surfaces that harbor the bacteria Close contact with an infected individual who has active symptoms Poor vaccination coverage increasing vulnerability
Key Symptoms: Sore throat and difficulty swallowing Gray or white coating on the throat and tonsils Fever and chills Swelling of the neck due to lymph node enlargement Malaise and fatigue Difficulty breathing due to airway obstruction Skin lesions in cutaneous diphtheria (less common)
Diagnostic & Treatment
Diagnosis Path: Diagnosing diphtheria involves a combination of clinical evaluation and laboratory testing. Healthcare providers will examine the signs and symptoms, especially the characteristic gray membrane in the throat. Throat swabs or tissue samples are collected to identify Corynebacterium diphtheriae through culture or PCR testing. Additional tests might be performed to assess the severity of the infection and any complications. Since diphtheria can be rapidly progressive and life-threatening, prompt diagnosis is essential.
Treatment Protocols: Treatment of diphtheria requires immediate medical intervention, typically involving antibiotics such as erythromycin or penicillin to eradicate the bacteria. Additionally, an injection of diphtheria antitoxin may be administered to neutralize the toxin produced by the bacteria. Patients may require hospitalization, particularly if airway management or supportive care is needed. Isolation precautions are important to prevent spread. Recovery depends on early detection and appropriate treatment, with some cases potentially leading to complications like myocarditis or nerve damage if not addressed promptly.
Clinical Advice & FAQs
Billing Guidance
Is A36.9 a billable ICD-10 code?
Yes, A36.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A36.9?
Clinical documentation must specify the nature of Diphtheria, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
